Catherine Brezault‐Bonnet

Author

Also Known As

C Brezault-Bonnet, C. Brezault-Bonnet, C. Brézault-Bonnet, Catherine Brezault-Bonnet, Catherine Brezault‐Bonnet, Catherine Brézault-Bonnet

Publications

239

Citations

H-Index

Concepts

All Affiliations

Inserm Hôpital Paul-Brousse Université Paris-Saclay Biotherapy of Genetic Diseases, Inflammatory Disorders and Cancers KU Leuven

About

Catherine Brezault‐Bonnet is an author at Inserm specializing in medicine, cancer research, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	125
2	Health Sciences	1	1	17
3	Cell Biology	1	1	46
4	Gastroenterology	1	1	17
5	Hepatology	1	1	17

Catherine Brezault‐Bonnet

Publications

218

Citations

H-Index

Page 1

	Year	Citations
Rescue chemotherapy using multidrug chronomodulated hepatic arterial infusion for patients with heavily pretreated metastatic colorectal cancer Mohamed Bouchahda, René Adam, Sylvie Giacchetti, Cancer	2009	57
Hepatocarcinoma-Intestine-Pancreas/Pancreatic Associated Protein (HIP/PAP) Is Expressed and Secreted by Proliferating Ductules as well as by Hepatocarcinoma and Cholangiocarcinoma Cells Laurence Christa, Marie‐Thérèse Simon, Catherine Brezault‐Bonnet, American Journal Of Pathology Protein FunctionSignal TransductionHepatocarcinoma-intestine-pancreas/pancreatic Associated ProteinCholangiocarcinoma CellsSignaling Pathway	1999	46
Prospective validation of a lymphocyte infiltration prognostic test in stage III colon cancer patients treated with adjuvant FOLFOX Jean‐François Emile, Catherine Julié, Karine Le Malicot, European Journal of Cancer Prognostic BiomarkersGastrointestinal OncologyMedicineImmunologyColorectal Cancer	2017	45
Chronomodulated Irinotecan, Oxaliplatin, and Leucovorin-Modulated 5-Fluorouracil as Ambulatory Salvage Therapy in Patients with Irinotecan- and Oxaliplatin-Resistant Metastatic Colorectal Cancer Dany Gholam, Sylvie Giacchetti, Catherine Brezault‐Bonnet, The Oncologist	2006	36
Chronotherapy of Colorectal Liver Metastases Francis Lévi, Sylvie Giacchetti, Rachid Zidani, HepatologyColorectal Liver MetastasesMedicineLiver PhysiologyHepatobiliary Tumor	2002	17
Gemcitabine plus nab-paclitaxel until progression or alternating with FOLFIRI.3, as first-line treatment for patients with metastatic pancreatic adenocarcinoma: The Federation Francophone de Cancérologie Digestive-PRODIGE 37 randomised phase II study (FIRGEMAX) Yves Rinaldi, Anne‐Laure Pointet, F. Khemissa Akouz, European Journal of Cancer Pancreatic CancerGastrointestinal OncologyCancérologie Digestive-prodige 37MedicinePathology	2020	17

Page 1